Veronika Alberg

Field of research

Physiologically based pharmacokinetic (PBPK) modeling

Curriculum vitae

Since 11/2024: Doctoral student Clinical Pharmacy, Saarland University, Saarbrücken

10/2023 – 11/2024: Master studentClinical Pharmacy, Saarland University, Saarbrücken

06/2023: Licensed as pharmacist

11/2022 – 04/2023: Practical year, Apotheke Feudenheim, Mannheim

05/2022 – 10/2022: Practical year, InfectoPharm Arzneimittel und Consilium GmbH, Heppenheim

11/2021 – 04/2022: Practical year, Roche, Mannheim

10/2017 – 09/2021: Pharmacy studies, Saarland University, Saarbrücken

06/2017: Abitur, Marie Luise-Kaschnitz-Gymnasium, Völklingen

Publications

Manuscripts

Dette CMU, Alberg V, Rüdesheim S, Selzer D, Marok FZ, Bragazzi NL, Fuhr LM, Brunak S, Pearson ER, Zahn T, Kiritsi D, Schwab M, Lehr T. Advancing rare disease therapeutics through digital twins: Opportunities in drug development and precision dosing. Comput Struct Biotechnol J. 2025;28:592-608.

Lehr T, Meiser P, Selzer D, Rixecker T, Holzer F, Mösges R, Smola S, Bals R, CONTAIN Study Group. Azelastine nasal spray for prevention of SARS-CoV-2 infections: A phase 2 randomized clinical trial. JAMA Intern Med. 2025.doi:10.1001/jamainternmed.2025.4283